165 related articles for article (PubMed ID: 35655778)
21. Castleman Disease and Rosai-Dorfman Disease.
Piris MA; Aguirregoicoa E; Montes-Moreno S; Celeiro-Muñoz C
Semin Diagn Pathol; 2018 Jan; 35(1):44-53. PubMed ID: 29217303
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
[TBL] [Abstract][Full Text] [Related]
23. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.
Hua Y; Liang C; Yang J; Wang L; Xu A; Xi L; Wang S; Wang Z
Am J Transl Res; 2022; 14(2):1051-1059. PubMed ID: 35273707
[TBL] [Abstract][Full Text] [Related]
25. Targeting the mTOR pathway in idiopathic multicentric Castleman disease.
Stern RM; Berliner N
J Clin Invest; 2019 Oct; 129(10):4086-4088. PubMed ID: 31524635
[TBL] [Abstract][Full Text] [Related]
26. Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Duminuco A; Romano A; Sabattini E; Villari L; Del Fabro V; Elia F; Palumbo GA; Di Raimondo F; Conticello C
Acta Haematol; 2023; 146(4):331-337. PubMed ID: 37068478
[TBL] [Abstract][Full Text] [Related]
27. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Castleman Disease.
Szalat R; Munshi NC
Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
[TBL] [Abstract][Full Text] [Related]
29. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
30. Castleman's disease of the spleen.
Mantas D; Damaskos C; Dailiani P; Samarkos M; Korkolopoulou P
Acta Chir Belg; 2017 Jun; 117(3):203-208. PubMed ID: 27771992
[TBL] [Abstract][Full Text] [Related]
31. Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease.
Pai RL; Japp AS; Gonzalez M; Rasheed RF; Okumura M; Arenas D; Pierson SK; Powers V; Layman AAK; Kao C; Hakonarson H; van Rhee F; Betts MR; Kambayashi T; Fajgenbaum DC
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376796
[TBL] [Abstract][Full Text] [Related]
32. A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome.
Ük E; Akın A; Gülseren ÜA; Erdem S; Medetalibeyoğlu A
Turk J Haematol; 2022 Aug; 39(3):215-217. PubMed ID: 35699306
[No Abstract] [Full Text] [Related]
33. Multifocal Castleman disease in pediatrics: case report.
Baserga M; Rosin M; Schoen M; Young G
J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
[TBL] [Abstract][Full Text] [Related]
34. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
[TBL] [Abstract][Full Text] [Related]
35. [Recent advances in diagnosis and treatment of idiopathic multicentric Castleman disease].
Okamoto S
Rinsho Ketsueki; 2019; 60(9):1205-1211. PubMed ID: 31597845
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.
Liu W; Cai Q; Yu T; Strati P; Hagemeister FB; Zhai Q; Zhang M; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Oksenhendler E; Xu-Monette ZY; Young KH; Yu L
Am J Cancer Res; 2022; 12(9):4227-4240. PubMed ID: 36225639
[TBL] [Abstract][Full Text] [Related]
37. Pathology of Castleman Disease.
Wu D; Lim MS; Jaffe ES
Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
[TBL] [Abstract][Full Text] [Related]
39. Unicentric Castleman's disease: an uncommon cause of chronic cough.
Bacha S; Zribi H; Habibech S; Attia M; Ayadi A; Mezni F; Chabbou A
Tunis Med; 2018 Feb; 96(2):148-151. PubMed ID: 30324981
[TBL] [Abstract][Full Text] [Related]
40. Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: Overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder.
Nakaya Y; Ishii N; Kasamatsu Y; Shimizu K; Tatsumi N; Tsutsumi M; Yoshida M; Yoshimura T; Hayashi Y; Nakao T; Inoue T; Yamane T
Pathol Int; 2020 Aug; 70(8):574-580. PubMed ID: 32449234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
